A newly-published set of recommendations advocates increased professional and patient awareness of MS-related cognitive symptoms and their management. The recommendations were endorsed by the U.S. National MS Society, the Consortium of Multiple Sclerosis Centers and the International MS Cognition Society (Kalb et al. Mult Scler 2018; epublished October 10, 2018). Use of the Symbol Digit Modalities Test (SDMT) or other validated test is advised early on when the patient is clinically stable, with re-assessments at least annually to detect new-onset cognitive impairment, detect disease activity and evaluate progression of cognitive impairment. Annual screening for depression is also recommended.